Zymeworks
$44.639876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$44.63
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$1.81 (-3.90%) Today
$0.00 (0.00%) As of 8:00 PM EST after-hours
Why Robinhood?
You can buy or sell Zymeworks and other stocks, options, ETFs, and crypto commission-free!
About ZYME
Zymeworks Inc., also called Zymeworks, is a clinical-stage biopharmaceutical company, which engages in the discovery, development and commercialization of biotherapeutics. Its product, ZW25 and ZW49 are a bispecific antibody that cans two non-overlapping epitopes. Read More The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani, and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada.
CEO
Employees
183
Headquarters
Vancouver, British Columbia
Founded
2003
Market Cap
2.14B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
240.55K
High Today
$46.20
Low Today
$44.63
Open Price
$45.16
Volume
221.74K
52 Week High
$52.75
52 Week Low
$14.05
Collections
Analyst Ratings
85%
of 13 ratings
Buy
85%
Hold
15%
Sell
0%
ZYME Earnings
-$0.67
-$0.34
-$0.00
$0.33
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
— per share
Actual
Expected Mar 5, After Hours
People Also Bought
Clovis Oncology
4,955
$11.10
+3.02%Tandem Diabetes Care
4,876
$88.30
-1.82%Plug Power
211,928
$5.60
+1.63%Adesto Technologies
3,058
$12.33
-0.16%Cronos Group
192,207
$7.12
-3.00%Lattice Semiconductor
2,634
$19.03
-0.83%Evolus
2,188
$10.33
-1.34%Sunrun
14,484
$21.63
-7.56%Chiasma
428
$4.60
+1.32%Ziopharm Oncology
2,540
$3.30
+1.23%Senseonics
12,383
$1.63
+5.16%Blueprint Medicines
762